![]() |
|
Ahmad Sh. Silmi Msc Haematology, FIBMS Increase platelet count for up to 10X106/ m3. Platelet clumping with bizarre shape. Marked platelet variation.
The-Non-leukaemic-Malignant-Disorders-ahmad.ppt - Search
ahmad
silmi
fibms
increase
platelet
count
10x106/
clumping
bizarre
marked
The Non-Leukaemic Lymphoproliferative Disorders . Ahmad Sh. Silmi. Msc Hematology, FIBMS. IUG
... increased megakaeryocytes, fibrosis & organomegaly blurs the boundaries Hepatosplenomegaly Sequestration of excess blood Extramedullary haematopoiesis Leukaemic ...
Myeloprolifirative disorders.ppt - Search
increased
fibrosis
organomegaly
blurs
boundaries
hepatosplenomegaly
sequestration
excess
blood
extramedullary
haematopoiesis
... Cytogenetic abnormality seen in 50% +8 Monosomy 7 del(7q) Monosomy 5 del (5q) del (20q) Complex karyotype Refractory cytopenia with multilineage dysplasia Leukaemic ...
NK/T - nasal, enteropathy assoc. 4. nodal - peripheral T-cell lymphoma, NOS, anaplastic large cell lymphoma Leukaemic T LGL indolent ATLL LA., PB, variants Mycosis ...
W T cell lymphoma.ppt - Search
enteropathy
nodal
peripheral
t-cell
anaplastic
large
lymphoma
indolent
variants
mycosis
... in their DNA sequence Enable dynamic control of genes in a context driven manner ie in time and space DNA methylation Histone acetylation Survival and leukaemic ...
Classifications Kiel REAL International working formula Rapport Lab investigations CBC leukaemic phase of lymphoma LDH B2 micro globulin ESR IG LFT KFT DX Tissue ...
Lymphoma.ppt - Search
classifications
international
working
formula
rapport
investigations
phase
micro
globulin
tissue
... usually CD5-, CD10-, CD23-, and CD43-negative, but the detection of one or, rarely, two of these antigens may be observed Berger et al. Blood 2000 n Splenic Leukaemic ...
Binding leads to antibody-dependent lysis of leukaemic cells. Bortezomib (Velcade) Acts as a reversible inhibitor of 26S proteasome activity.
The Therapeutics of Leukaemia Lymphoma and Myeloma2.ppt - Search
binding
leads
antibody-dependent
lysis
bortezomib
reversible
inhibitor
proteasome
Others Invx 8.Lumbar puncture initial staging inv. to detect leukaemic cells in the cerebrospinal fluid, indicating involvement of the CNS Done in acute lymphoblastic ...
... 1969 1200kg bark -> 28kg crude extract -> 10g pure 1975 active in another in vitro assay 1977 7000 pounds bark requested to make 600g 1978 Mildly active in leukaemic ...
management of p.r.v prevention of vascular occlusions delay myelofibrotic transformation minimize acute leukaemic transformation. phlebotomy myelosuppressive antiplatelet ...
... Leukaemia (AML) Uncontrolled proliferation of immature myeloid cells (blast) Median age of onset ~60 years Analysis to look for ACQUIRED abnormalities in leukaemic ...
JS1 CMGS 2010 Stanley.ppt - Search
leukaemia
uncontrolled
proliferation
immature
myeloid
cells
median
onset
years
analysis
acquired
abnormalities
... Aracne (transcription factor binding) export export Protein and gene interaction network connecting ID2 to apoptosis in BCLL Analysis of apoptotic response of leukaemic ...
... the study of highly specific T-cell subsets Lymphocyte subsets Oncology immunophenotyping HLA-B27 Progenitor cell enumeration (CD34) Immunophenotyping of leukaemic ...
BS962 NF Lec 1 (2011).ppt - Search
study
highly
specific
subsets
lymphocyte
oncology
immunophenotyping
hla-b27
progenitor
enumeration
Myeloproliferative Disorders Clonal, pre-leukaemic Uncontrolled proliferation of one or more bone marrow lineages: Red cells – primary polycythaemia Platelets ...
AML, M5. leukaemic . infiltration. of the gums. expansion and. thickening. partial coverings. of the teeth
... recombinant form expressed in the bacteria Action: catalyses the conversion of the AA L-asparagine to L-aspartic acid reducing availability of L-asparagine to leukaemic ...
1978 Mildly active in leukaemic mice; 1979 Horowitz; unknown mechanism; involved stabilising of microtubules; 1980 20,000 pounds of bark needed
The goal is to eradicate the leukaemic cell mass while giving supportive care. In children with ALL postremission therapy includes central nervous system (CNS) prophylaxis.
|
Hot Documents barrascoagulase-negativo 輻合區 rifaat 何俊億 kompensasi pastorais rock-mechanic komisje engine-cooling-system |